Patents by Inventor Paul B. Sigler

Paul B. Sigler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7314620
    Abstract: Methods for treatment, diagnosis, and screening are provided for diseases or conditions characterized by an abnormality in a signal transduction disorder. The signal transduction pathway involves an interaction between a PH domain and a PH domain binding partner.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: January 1, 2008
    Assignee: New York University
    Inventors: Mark A. Lemmon, Kathryn M. Ferguson, Paul B. Sigler, Joseph Schlessinger
  • Publication number: 20040186079
    Abstract: Methods for treatment, diagnosis, and screening are provided for diseases or conditions characterized by an abnormality in a signal transduction disorder. The signal transduction pathway involves an interaction between a PH domain and a PH domain binding partner.
    Type: Application
    Filed: December 18, 2003
    Publication date: September 23, 2004
    Applicant: New York University
    Inventors: Mark A. Lemmon, Kathryn M. Ferguson, Paul B. Sigler, Joseph Schlessinger
  • Patent number: 6054280
    Abstract: Methods for treatment, diagnosis, and screening are provided for diseases or conditions characterized by an abnormality in a signal transduction disorder. The signal transduction pathway involves an interaction between a PH domain and a PH domain binding partner.
    Type: Grant
    Filed: March 20, 1995
    Date of Patent: April 25, 2000
    Inventors: Mark A. Lemmon, Kathryn M. Ferguson, Paul B. Sigler, Joseph Schlessinger